Muller & Phipps (India) Limited (BOM:501477)
212.00
-11.00 (-4.93%)
At close: Jun 1, 2026
Muller & Phipps (India) Revenue
In the fiscal year ending March 31, 2026, Muller & Phipps (India) had annual revenue of 69.08M INR with 11.51% growth. Muller & Phipps (India) had revenue of 15.81M in the quarter ending March 31, 2026, a decrease of -10.34%.
Revenue
69.08M
Revenue Growth
+11.51%
P/S Ratio
1.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
132.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 69.08M | 7.13M | 11.51% |
| Mar 31, 2025 | 61.94M | 17.65M | 39.83% |
| Mar 31, 2024 | 44.30M | 2.62M | 6.29% |
| Mar 31, 2023 | 41.68M | 2.38M | 6.04% |
| Mar 31, 2022 | 39.30M | -2.96M | -7.01% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.74B |
| Dipna Pharmachem | 1.07B |
| Medico Intercontinental | 853.55M |
| Medistep Healthcare | 708.54M |
| Chandra Bhagat Pharma | 493.95M |
| Zenlabs Ethica | 471.07M |
| Evoq Remedies | 267.57M |
| Pentokey Organy (India) | 24.98M |